Spiked sample preparation for recovery, matrix effect and QC checks
Why spiked sample preparation matters
Spiked sample preparation is the controlled addition of a known analyte, surrogate or standard to a sample, blank or matrix before a defined analytical workflow. The purpose is not simply to create a positive sample. A well-designed spike helps a laboratory separate instrument response from extraction efficiency, digestion loss, matrix interference, dilution error, contamination and operator variability. In regulated bioanalysis, FDA guidance uses spiked samples as a general term for calibrators and quality controls, while ICH M10 places calibration standards and QC samples at the center of validated bioanalytical runs. In environmental testing, matrix spikes and matrix spike duplicates are used to assess how a real sample matrix affects recovery and precision. (fda.gov)
The practical point is straightforward: a spike is useful only when the added material, matrix, concentration, timing and preparation path are defined before the analyst starts pipetting. Poorly planned spikes can generate numbers, but they do not necessarily generate reliable evidence. For more workflow-focused articles, visit our sample preparation section.
What a spiked sample can and cannot prove
A spiked sample answers a controlled question: if a known amount is added, how much can the method recover after the specified preparation and analysis steps? That makes spiking valuable for method validation, routine QC, troubleshooting and batch review. It does not prove that every unspiked sample is free from bias, and it does not automatically identify the exact cause of poor recovery. It narrows the investigation by comparing expected and measured response under documented conditions.
| Spiked or QC item | Main question it answers | Important limitation |
|---|---|---|
| Calibration standard | How does response relate to known concentration? | It is not a replacement for an independently prepared QC sample. |
| Quality control sample | Is the run performing within predefined limits? | It reflects the selected QC levels, not every possible sample condition. |
| Laboratory control sample | Can the method recover analyte in a controlled or clean matrix? | It may not show interference from a difficult real matrix. |
| Matrix spike | Does the actual sample matrix suppress, enhance or reduce recovery? | It usually represents one selected sample, not all samples in a project. |
| Matrix spike duplicate | How reproducible is recovery in that matrix? | It reflects both preparation and analysis variability for the duplicate pair. |
| Surrogate or internal standard | Did a monitored compound experience loss or response change? | It may not behave exactly like every target analyte. |
EPA quality control guidance describes laboratory control samples, matrix spikes, blanks and duplicate measurements as different QC elements with different purposes. This distinction matters in batch review. A passing LCS may show that the laboratory process is under control in a clean or controlled matrix, while a failed matrix spike may point to interference or recovery loss in a particular sample matrix. (epa.gov)
Design choices before preparing spikes
Choose a matrix that matches the decision
The matrix should match the decision being supported. For a calibration curve in bioanalysis, the preferred matrix is usually the same biological matrix as the study sample when it is available and suitable. When a surrogate matrix is used, ICH M10 notes that stability may need to be demonstrated in the surrogate matrix because stability can differ from the authentic matrix. The same principle applies outside bioanalysis: convenience matrices can be practical, but they should not be treated as identical without evidence. (database.ich.org)
Select concentration levels that are meaningful
Spike levels should be tied to the decision being made. A level near the reporting limit can test whether low concentrations survive preparation. A mid-range level can assess routine method behavior. A high level can reveal saturation, nonlinearity or carryover risks. For validation, multiple levels are often needed because recovery and matrix effects can change across the calibration range. For routine QC, the method, SOP or project quality plan should define the required levels and acceptance criteria.
Decide when the spike enters the workflow
Timing is one of the most important choices in spiked sample preparation. If the goal is whole-process recovery, the spike should normally enter before extraction, digestion, cleanup or evaporation. If the goal is to isolate instrument response, a post-extraction spike may be more informative. Some methods also include specific timing instructions. For certain SW-846 organic extraction methods, an EPA memorandum recommended adding surrogates and spike compounds after drying agents rather than before them to prevent low recoveries for some semi-volatile and non-volatile organic compounds. That example shows why method-specific instructions should override generic habit. (epa.gov)
Control the added volume and solvent
The spike solution should be concentrated enough that the added volume does not materially change the sample matrix, unless dilution is part of the design. The solvent should be compatible with the sample and preparation chemistry. Large organic solvent additions to aqueous or biological samples, for example, may change protein binding, extraction partitioning or precipitation behavior. The exact spike volume, stock concentration, lot number, expiration or preparation date and analyst should be traceable in the worksheet or laboratory information system.
A practical workflow and calculation checks
- Define the purpose. State whether the spike is for calibration, recovery, matrix effect, precision, batch control or troubleshooting.
- Select the matrix. Use authentic matrix when required and feasible; document any surrogate matrix and why it is acceptable.
- Prepare or verify the stock solution. Confirm identity, concentration, purity, storage condition and stability window according to the applicable method or SOP.
- Calculate the addition. Record target concentration, original sample amount, spike concentration and final volume or mass basis.
- Spike at the planned step. Add the spike before or after preparation steps according to the question being tested.
- Mix and equilibrate consistently. Vortexing, shaking, sonication, homogenization or standing time should be defined rather than improvised.
- Prepare unspiked and blank controls in parallel. The comparison is weak if the unspiked sample, method blank or LCS does not follow the same workflow.
- Analyze and review against predefined criteria. Avoid changing acceptance limits after seeing the result.
The most common recovery calculation is: recovery (%) = (measured concentration in the spiked aliquot – measured concentration in the unspiked aliquot) / known concentration added × 100. For a matrix spike duplicate pair, relative percent difference is often calculated as the absolute difference between the two results divided by their average, multiplied by 100.
These calculations are simple; interpretation is not. Acceptance limits must come from the validated method, regulatory method, SOP or project quality objective, not from a universal rule of thumb. The same recovery value may be acceptable in one trace-level, complex-matrix application and unacceptable in a tightly controlled quantitative method.
Preparation batches also matter. EPA SW-846 Method 8260D, for example, describes sample QC for preparation and analysis and refers to a method blank, laboratory control sample and, where practical, a laboratory sample duplicate/matrix spike or matrix spike/matrix spike duplicate in each preparation batch of 20 or fewer samples. The point is not that every laboratory should copy one method into another field, but that spikes are normally interpreted within a defined batch structure. (epa.gov)
How expectations differ by application
Spiked sample preparation is used across analytical chemistry, but the intent changes by application. A bioanalytical laboratory validating an LC-MS/MS method, an environmental laboratory applying an SW-846 method and a research laboratory developing a new extraction method may all prepare spikes. The evidence they need, however, is not the same. See also: buying guides.
| Application | Typical spiking focus | What readers should verify |
|---|---|---|
| Bioanalytical method validation | Calibration standards, QC samples, selectivity, accuracy, precision and stability support study sample analysis. | Whether the method follows the applicable FDA guidance, ICH M10 expectations and the sponsor-approved validation plan. |
| Environmental testing | Matrix spikes, matrix spike duplicates, blanks and LCS results help assess batch quality, matrix effects and precision. | Whether the project method requires a specific batch frequency, matrix category and recovery limit. |
| Food, chemical or materials testing | Recovery studies often test extraction efficiency, digestion completeness or interference from fats, salts, polymers or additives. | Whether the spike level reflects the regulatory, safety or specification decision being made. |
| Research method development | Pre- and post-extraction spikes may be compared to separate extraction loss from ion suppression or enhancement. | Whether the experiment is exploratory or formally validated for decision-making use. |
FDA finalized its Bioanalytical Method Validation guidance in 2018, and ICH M10 reached Step 4 in 2022. Together, these sources have made terminology such as calibration standards, quality controls, matrix effects and stability more harmonized for bioanalytical work. Environmental methods remain method-specific; EPA guidance and SW-846 method language should be read for the exact batch and QC requirements that apply to the analytes and matrix at hand. (fda.gov)
Preparation errors that often explain poor recovery
When spike recovery fails, the instrument is not always the first suspect. Many failures start at the preparation bench. A heterogeneous soil, tissue, powder or slurry may give different aliquots different starting concentrations. A spike placed on the wall of a tube rather than into the sample may not fully mix. Evaporation to dryness can lose volatile analytes or make reconstitution inconsistent. Digestion blocks, centrifuges, homogenizers, SPE manifolds, nitrogen evaporators, vortex mixers and analytical balances all contribute to reproducibility when they are used consistently and maintained properly.
- Inadequate homogenization: the spiked aliquot and unspiked aliquot are not comparable before preparation starts.
- Wrong spike timing: a post-extraction spike is interpreted as whole-method recovery, or a pre-extraction spike is used when the goal was instrument response only.
- Too much spike solvent: the added solvent changes extraction behavior, precipitation or analyte binding.
- Carryover from high spikes: a high-level spike contaminates later injections or preparation tools.
- Uncontrolled evaporation: different dryness endpoints change final concentration or analyte stability.
- Unclear mass or volume basis: wet weight, dry weight, final extract volume and dilution factors are mixed in calculation records.
- Shared glassware or tools: residues from standards or previous samples create false recovery or blank contamination.
A useful investigation compares the failed spike with the method blank, LCS, unspiked sample, duplicate, calibration verification and instrument performance. If the LCS passes but the matrix spike fails, the evidence leans toward sample-specific matrix effects or recovery loss. If both fail, the issue may be broader, such as standard preparation, extraction chemistry, instrument calibration or contamination. This is editorial analysis based on standard QC logic; the final conclusion should always be tied to the applicable method and laboratory quality system.
Frequently asked questions
Is a spiked sample the same as a matrix spike?
No. A spiked sample is a broad term for a sample, blank or matrix to which a known amount has been added. A matrix spike is more specific: it is an aliquot of an actual sample matrix fortified with target analyte to evaluate recovery in that matrix.
Should the spike be added before or after extraction?
It depends on the question. Add the spike before extraction, digestion or cleanup when evaluating whole-process recovery. Add it after extraction when the goal is to study instrument response or post-preparation matrix effects. If a regulatory or validated method specifies timing, follow that method.
What recovery percentage is acceptable?
There is no universal acceptable recovery for every analyte, matrix and method. The valid range should come from the regulatory method, validation protocol, SOP or project quality objective. A narrow range may be appropriate for a robust quantitative method, while a broader range may be justified for trace-level, complex-matrix screening work.
Can an internal standard replace a matrix spike?
Usually no. An internal standard can correct or monitor certain losses and response changes, especially when it closely resembles the analyte. A matrix spike directly tests recovery of added target analyte in a selected sample matrix. The two tools can complement each other, but they answer different QC questions.
Why can a clean laboratory control sample pass while a matrix spike fails?
A laboratory control sample checks the method in a controlled matrix, while a matrix spike challenges the method in a real sample matrix. A pass-fail difference can indicate matrix suppression, enhancement, incomplete extraction, binding, co-extracted interferences or sample heterogeneity. The result should trigger a structured review rather than an automatic rejection of all data.
